Early stage health care investor Arboretum Ventures has raised $70.2 million toward a new $125 million fund, representing a significant expansion of the firm. The partnership, based in Ann Arbor, Mich., released the news in a filing with the Securities and Exchange Commission on Wednesday. The 8-year-old firm is now investing its second fund and [...]

Could Twitter Sell? If so, that secondary stake play was a great move…

Deals: Visa targets PlaySpan, Deutsche Börse/NYSE Euronext

Un-Stimulus: GOP proposes a wave of federal budget cuts

Smooth it Out: Nestle/L’Oreal venture Galderma ups Q-Med bid

PathCentral said Tuesday that it has raised $10 million in Series B financing. Okapi Venture Capital, Arboretum Ventures, and Baird Venture Partners co-led the round. Irvine, Calif.-based PathCentral is an anatomic pathology services company. Okapi Venture Capital is a seed and early stage life sciences and information technology investor. Arboretum Ventures, of Ann Arbor, Mich., is an early stage VC firm that focuses on healthcare services. Baird Venture Partners is the VC fund of Baird Private Equity.

George Dunbar has joined Ann Arbor, Mich.-based Arboretum Ventures as a venture partner. Last month he stepped down as president and CEO of stem cell company Aastrom Biosciences Inc. (Nasdaq: ASTM). Prior CEO jobs have been with Quantum Dot (bought by Invitrogen) and Epic Therapeutics (Baxter). www.arboretumvc.com

CerviLenz Inc., a Cleveland-based maker of disposable devices used to predict the risk of preterm birth in pregnant women, has raised $4 million in first-round funding. Arboretum Ventures led the round, and was joined by Chrysalis Ventures. PRESS RELEASE CerviLenz Inc., a manufacturer and distributor of a disposable device used to predict the risk of preterm [...]

Arboretum Ventures has closed its second fund with $73 million in capital commitments. The Ann Arbor, Mich.-based firm focuses on healthcare and life sciences opportunities, and had raised $24 million for its debut fund in 2005.

Arboretum Ventures has received a $5 million commitment from its second fund, from the Renaissance Venture Capital Fund, a new venture fund-of-funds focused on the Michigan market. This is Renaissance’s first commitment.

New Brunswick, NJ, (October 27, 2008) – As an initial step in the creation of a wellness and prevention business platform, Johnson & Johnson announced today it has acquired HealthMedia, Inc., a privately held company located in Ann Arbor, Michigan, that creates web-based behavior change interventions. Terms of the transaction were not disclosed. HealthMedia combines [...]